Badge

Lunesta Canada Pharmacy Announces its Canadian Generic Shipping Promotion

March 15, 2015
Top Quote SaveRxCanada.com, a Lunesta Canada pharmacy intermediary for over 13 years announces its free shipping promotion. End Quote
    logo_save_rx_canada
    QuoteSaveRxCanada.com has been the premier Lunesta Canada pharmacy broker for over 13 years providing savings to customers world wide.Quote
  • (1888PressRelease) March 15, 2015 - SaveRxCanada.com announces the addition of Lunesta to its International Generics Program (IGP) promotion. Lunesta is used to treat insomnia. This medicine causes relaxation to help you fall asleep and stay asleep.

    Through SaveRxCanada.com, the International Generics Program is aimed at providing customers with the generic versions of medications that are currently only available as brand names in Canada.

    As a bonus, customers will benefit from free shipping on any order for prescription medication that is part of our International Generics Program and valued over $99.00 USD.

    Price quotes for Lunesta (eszopiclone) 1mg/2mg/3mg can be found on the SaveRxCanada.com website at http://www.saverxcanada.com/drugs/lunesta

    About SaveRxCanada.com
    SaveRxCanada.com has been is a trusted, affordable, and reliable Canadian pharmacy intermediary for over 13 years. The cost of Canadian prescription drugs in many parts of the world have been rising rapidly leaving many uninsured and underinsured people with no reasonable way to obtain their needed medications.

    SaveRxCanada.com is a Canadian pharmacy broker, negotiating the best prices for its clientele.

    All prescriptions are dispensed by licensed pharmacies and pharmacists located in Canada, Italy, the UK, New Zealand, India, Switzerland, South Africa, Israel, and Fiji.

    For further information on price quotes, placing a new order, and shipping information, visit http://www.saverxcanada.com

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information
Over Satisfied Users & Approved Press Releases
© Copyright 2005-2024, 1888 Press Release. All Rights Reserved